ESPI/EBI reports

Audited consolidated and unconsolidated annual report of company Krka, d. d., Novo mesto for the year 2025 KRKA. TOVARNA ZDRAVIL. D.D.. NOVO MESTO (SI0031102120)

09-04-2026 08:16:00 | ESPI | 18/2026
oUNI-EN: Audited consolidated and unconsolidated annual report of company Krka, d. d., Novo mesto for the year 2025

PAP
Data: 2026-04-09

Firma: KRKA, TOVARNA ZDRAVIL D.D.

oSpis tresci:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

oSpis zalacznikow:
Znaleziono 1 załącznik
  • 549300H9RLRTRTLRUZ73-2025-12-31-1-en.xbri
  • Arkusz: REPORT

    Nazwa arkusza: REPORT


    POLISH FINANCIAL SUPERVISION AUTHORITY
    UNI - EN REPORT No 18 / 2026
    Date of issue: 2026-04-09
    Short name of the issuer
    KRKA
    Subject
    Audited consolidated and unconsolidated annual report of company Krka, d. d., Novo mesto for the year 2025
    Official market - legal basis
    Art. 56. 1. 2 of Act on Public Offering
    Unofficial market - legal basis
    Contents of the report:
    Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 134 of the Market in Financial Instruments Act, Krka, d. d., Novo mesto publishes the Audited consolidated and unconsolidated annual report for the year 2025.

    The report is in the official ESEF format and represents the fulfilment of the obligation to disclose the annual report in accordance with the first paragraph of Article 134 of ZTFI-1 and Commission Delegated Regulation _EU_ 2019/815.

    The company Krka, d. d., Novo mesto has additionally prepared an unofficial version of the Audited consolidated and unconsolidated annual report for the year 2025 in PDF format that is published on the Company's website under section Financial reports.The report will be published on the Company's website _www.krka.biz_ from 9 April 2026 onwards, for a period of at least 10 years.
    Annexes
    File Description
    549300H9RLRTRTLRUZ73-2025-12-31-1-en.xbri Annual report 2025

    Nazwa arkusza: INFORMATION ABOUT THE ENTITY


    KRKA, TOVARNA ZDRAVIL D.D.
    _fullname of the issuer_
    KRKA Farmaceutyczny _far_
    _short name of the issuer_ _sector according to clasification
    of the WSE in Warsow_
    8501 Nove Mesto
    _post code_ _city_
    Smarjeska 6
    _street_ _number_
    +386 7 331 21 11 +386 7 332 15 37
    _phone number_ _fax_
    _e-mail_ _web site_
    nie dotyczy
    _NIP_ _REGON_

    Nazwa arkusza: SIGNATURE OF PERSONS REPRESENTING THE COMPANY


    SIGNATURE OF PERSONS REPRESENTING THE COMPANY
    Date Name Position / Function Signature
    2026-04-09 Jože Colarič President of the Management Board and CEO


    Identyfikator raportu jjvuszwyf1
    Nazwa raportu UNI-EN
    Symbol raportu UNI-EN
    Nazwa emitenta KRKA, TOVARNA ZDRAVIL D.D.
    Symbol Emitenta KRKA
    Tytul Audited consolidated and unconsolidated annual report of company Krka, d. d., Novo mesto for the year 2025
    Sektor Farmaceutyczny (far)
    Kod 8501
    Miasto Nove Mesto
    Ulica Smarjeska
    Nr 6
    Tel. +386 7 331 21 11
    Fax +386 7 332 15 37
    e-mail
    NIP nie dotyczy
    REGON
    Data sporzadzenia
    Rok biezacy 2026
    Numer 18
    adres www
    Serwis Ekonomiczny Polskiej Agencji Prasowej SA 2026 Copyright PAP SA - Wszelkie prawa zastrzezone.